Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021

por Sehdev, Sandeep, Chambers, Alexandra
Publicado 2022

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules

por Kaplan, Alan, Stewart, David J., Batist, Gerald, Spadafora, Silvana, Sehdev, Sandeep, Goodman, Shaun G.
Publicado 2022

Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic

por Tse, Tabitha, Sehdev, Sandeep, Seely, Jean, Gravel, Denis H., Clemons, Mark, Cordeiro, Erin, Arnaout, Angel
Publicado 2021

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

por Yang, Charlie, Brezden-Masley, Christine, Joy, Anil Abraham, Sehdev, Sandeep, Modi, Shanu, Simmons, Christine, Henning, Jan-Willem
Publicado 2023

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc...

por Rayson, Daniel, Gandhi, Sonal, Joy, Anil A., Brezden-Masley, Christine, Gelmon, Karen A., Sehdev, Sandeep, Cescon, David, Chia, Stephen
Publicado 2023

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain

por Rayson, Daniel, Gandhi, Sonal, Joy, Anil A., Brezden-Masley, Christine, Gelmon, Karen A., Sehdev, Sandeep, Cescon, David, Chia, Stephen
Publicado 2022

HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review

por Jerzak, Katarzyna J., Bouganim, Nathaniel, Brezden-Masley, Christine, Edwards, Scott, Gelmon, Karen, Henning, Jan-Willem, Hilton, John F., Sehdev, Sandeep
Publicado 2023

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

por McGee, Sharon, AlZahrani, Mashari, Stober, Carol, Ng, Terry L., Cole, Katherine, Larocque, Gail, Awan, Arif, Sehdev, Sandeep, Hilton, John, Vandermeer, Lisa, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Clemons, Mark
Publicado 2021

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey

por Alzahrani, Mashari, Clemons, Mark, Sienkiewicz, Marta, Shrem, Noa Shani, McGee, Sharon F., Vandermeer, Lisa, Sehdev, Sandeep, Savard, Marie France, Awan, Arif, Canil, Christina, Hutton, Brian, Pond, Gregory, Saunders, Deanna, Ng, Terry
Publicado 2021

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

por Papp, Kim A., Melosky, Barbara, Sehdev, Sandeep, Hotte, Sebastien J., Beecker, Jennifer R., Kirchhof, Mark G., Turchin, Irina, Dutz, Jan P., Gooderham, Melinda J., Gniadecki, Robert, Hong, Chih-ho, Lambert, Jo, Lynde, Charles W., Prajapati, Vimal H., Vender, Ronald B.
Publicado 2023

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Pa...

por Papp, Kim A., Melosky, Barbara, Sehdev, Sandeep, Hotte, Sebastien J., Beecker, Jennifer R., Kirchhof, Mark G., Turchin, Irina, Dutz, Jan P., Gooderham, Melinda J., Gniadecki, Robert, Hong, Chih-ho, Lambert, Jo, Lynde, Charles W., Prajapati, Vimal H., Vender, Ronald B.
Publicado 2023